1
|
Astragaloside IV: A promising natural neuroprotective agent for neurological disorders. Biomed Pharmacother 2023; 159:114229. [PMID: 36652731 DOI: 10.1016/j.biopha.2023.114229] [Citation(s) in RCA: 9] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Revised: 01/05/2023] [Accepted: 01/05/2023] [Indexed: 01/18/2023] Open
Abstract
Neurological disorders are characterized by high morbidity, disability, and mortality rates, which seriously threaten human health. However, clinically satisfactory agents for treatment are still currently lacking. Therefore, finding neuroprotective agents with minimum side effects and better efficacy is a challenge. Chinese herbal medicine, particularly natural preparations extracted from herbs or plants, has become an unparalleled resource for discovering new agent candidates. Astragali Radix is an important Qi tonic drug in traditional Chinese medicine and has a long medicinal history. As a natural medicine, it has a good prevention and treatment effect on neurological disorders. Here, the role and mechanism of astragaloside IV in the treatment of neurological disorders were evaluated and discussed through previous research results. Related information from major scientific databases, such as PubMed, MEDLINE, Web of Science, ScienceDirect, Embase, BIOSIS Previews, and the Cochrane Central Register of Controlled Trials and Cochrane Library, covering between 2001 and 2021 was compiled, using "Astragaloside IV" and "Neurological disorders," "Astragaloside IV," and "Neurodegenerative diseases" as reference terms. By summarizing previous research results, we found that astragaloside IV may play a neuroprotective role through various mechanisms: anti-inflammatory, anti-oxidative, anti-apoptotic protection of nerve cells and regulation of nerve growth factor, as well as by inhibiting neurodegeneration and promoting nerve regeneration. Astragaloside IV is a promising natural neuroprotective agent. By determining its pharmacological mechanism, astragaloside IV may be a new candidate drug for the treatment of neurological disorders.
Collapse
|
2
|
Zhou Z, Huang Y, Xiao J, Liu H, Wang Y, Gong Z, Li Y, Wang A, Li Y, Zheng L. Chemical profiling and quantification of multiple components in Jin‐Gu‐Lian Capsule using a multivariate data processing approach based on UHPLC‐Orbitrap Exploris 240 MS and UPLC‐MS/MS. J Sep Sci 2022; 45:1282-1291. [DOI: 10.1002/jssc.202100762] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2021] [Revised: 01/06/2022] [Accepted: 01/16/2022] [Indexed: 11/08/2022]
Affiliation(s)
- Zu‐Ying Zhou
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
- School of Pharmaceutical Guizhou Medical University Guiyang 550004 China
| | - Yong Huang
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
| | - Jin‐Chao Xiao
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
- School of Pharmaceutical Guizhou Medical University Guiyang 550004 China
| | - Hui Liu
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
- School of Pharmaceutical Guizhou Medical University Guiyang 550004 China
| | - Yong‐Lin Wang
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
| | - Zi‐Peng Gong
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
| | - Yue‐Ting Li
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
| | - Ai‐Min Wang
- Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education) Guizhou Medical University Guiyang 550004 China
| | - Yong‐Jun Li
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
| | - Lin Zheng
- State Key Laboratory of Functions and Applications of Medicinal Plants Guizhou Provincial Key Laboratory of Pharmaceutics Guizhou Medical University Guiyang 550004 China
| |
Collapse
|
3
|
Ji Z, Jiang Y, Lin H, Ren W, Lin L, Guo H, Huang J, Li Y. Global identification and quantitative analysis of representative components of Xin-Nao-Kang Capsule, a traditional Chinese medicinal formula, by UHPLC-Q-TOF-MS and UHPLC-TQ-MS. J Pharm Biomed Anal 2021; 198:114002. [PMID: 33706143 DOI: 10.1016/j.jpba.2021.114002] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Revised: 02/09/2021] [Accepted: 03/01/2021] [Indexed: 11/28/2022]
Abstract
Xin-Nao-Kang Capsule (XNKC), a well-known traditional Chinese medicine (TCM), is widely used for the treatment of angina pectoris, cerebral arteriosclerosis and coronary artery disease in China. However, the chemical components have not been holistically explored. In this study, a total of 173 chemical components including 48 flavonoids, 8 lactones, 35 acids, 12 phenanthraquinones, 8 monoterpene glycosides, 32 triterpenoids and 30 other compounds were identified, among which 37 were unambiguously characterized in comparison with their corresponding authentic standards using ultra-high performance liquid chromatography coupled with quadruple time-of-flight tandem mass spectrometry (UHPLC-Q-TOF-MS). To further elucidate the major representative constitutes of XNKC, a high performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry (UHPLC-TQ-MS) method was used for simultaneous quantitative analysis of 34 major representative constitutes in ten batches of XNKC samples, which was validated in terms of linearity, precision, accuracy, repeatability and recovery. Meanwhile, the results of chemometric analysis indicated that puerarin and salvianolic acid B might be the most potential quantitative markers for quality control of XNKC. Taken together, the chemical constitutes of XNKC were systematically identified and a reliable quantitative method coupled with chemometric analysis was successfully employed for evaluating the holistic quality of XNKC. This study will provide a robust foundation for the holistic quality assessment of XNKC.
Collapse
Affiliation(s)
- Zhengchao Ji
- Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China
| | - Yi Jiang
- Department of Breast Disease, The Second Hospital of Jilin University, Changchun, China
| | - Hua Lin
- Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China
| | - Wenbo Ren
- Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China
| | - Lin Lin
- Traditonal Chinese Medicine Department, Heilongjiang Institute for Drug Control, Harbin, China
| | - Haiyang Guo
- Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China
| | - Jing Huang
- Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China.
| | - Yanyan Li
- Department of Laboratory Medicine, The First Hospital of Jilin University, Changchun, China.
| |
Collapse
|
4
|
Fu R, Wang W, Tao H, Wang M, Chen Y, Gao H, Yue S, Tang Y. Quantitative evaluation of Danqi tablet by ultra‐performance liquid chromatography coupled with triple quadrupole mass spectrometry integrated with bioassay. J Sep Sci 2021; 44:1552-1563. [DOI: 10.1002/jssc.202000932] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2020] [Revised: 12/11/2020] [Accepted: 01/17/2021] [Indexed: 01/01/2023]
Affiliation(s)
- Rui‐Jia Fu
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility and State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation) and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research and Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization Shaanxi University of Chinese Medicine Xi′an P. R. China
| | - Wen‐Xiao Wang
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility and State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation) and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research and Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization Shaanxi University of Chinese Medicine Xi′an P. R. China
| | - Hui‐Juan Tao
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility and State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation) and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research and Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization Shaanxi University of Chinese Medicine Xi′an P. R. China
| | - Mei Wang
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility and State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation) and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research and Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization Shaanxi University of Chinese Medicine Xi′an P. R. China
| | - Yan‐Yan Chen
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility and State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation) and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research and Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization Shaanxi University of Chinese Medicine Xi′an P. R. China
| | - Huan Gao
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility and State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation) and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research and Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization Shaanxi University of Chinese Medicine Xi′an P. R. China
| | - Shi‐Jun Yue
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility and State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation) and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research and Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization Shaanxi University of Chinese Medicine Xi′an P. R. China
| | - Yu‐Ping Tang
- Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility and State Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation) and Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research and Shaanxi Collaborative Innovation Center of Chinese Medicinal Resources Industrialization Shaanxi University of Chinese Medicine Xi′an P. R. China
| |
Collapse
|
5
|
Wang Q, Zou Z, Zhang Y, Lin P, Lan T, Qin Z, Xu D, Wu H, Yao Z. Characterization of chemical profile and quantification of major representative components of Wendan decoction, a classical traditional Chinese medicine formula. J Sep Sci 2021; 44:1036-1061. [PMID: 33403778 DOI: 10.1002/jssc.202000952] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2020] [Revised: 11/22/2020] [Accepted: 12/26/2020] [Indexed: 12/13/2022]
Abstract
Wendan decoction, a classical traditional Chinese medicine formula consisting of six herbal medicines, has been widely used in clinical treatments for thousands of years due to the expectorant effects. However, the chemical basis of Wendan decoction remains unclear, which hinders the elucidation of the scientific connotation and mechanism of its effective components. In this study, an ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry method was first developed for characterization of its chemical profile, and a total of 142 chemical components including flavonoids, triterpenoids, alkaloids, coumarins, pungent phytochemicals, and other types were detected, among which 41 components were definitively identified with authentic standards. Furthermore, 14 major representative components were simultaneously quantified by high-performance liquid chromatography with ultraviolet detector, indicating that the content levels of flavonoids were the most abundant in Wendan decoction. In summary, this study established sensitive and practical methods to systematically characterize chemical profile for the first time and simultaneous quantify representative components of Wendan decoction. These findings above would provide a solid chemical basis for disclosure of potential effective components by further in vivo disposal study, and promote therapeutic mechanism researches of Wendan decoction.
Collapse
Affiliation(s)
- Qi Wang
- College of Pharmacy, Jinan University, Guangzhou, P.R. China
| | - Zhenyu Zou
- College of Pharmacy, Jinan University, Guangzhou, P.R. China
| | - Yezi Zhang
- College of Pharmacy, Jinan University, Guangzhou, P.R. China
| | - Pei Lin
- College of Pharmacy, Jinan University, Guangzhou, P.R. China
| | - Taohua Lan
- Department of Cardiology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, P.R. China
| | - Zifei Qin
- College of Pharmacy, Jinan University, Guangzhou, P.R. China.,Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China
| | - Danping Xu
- Department of Cardiology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, P.R. China
| | - Huanlin Wu
- Department of Cardiology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, P.R. China
| | - Zhihong Yao
- College of Pharmacy, Jinan University, Guangzhou, P.R. China.,International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, Guangzhou, P.R. China
| |
Collapse
|
6
|
Gao X, Hu X, Zhang Q, Wang X, Wen X, Wang Y, Zhang Y, Sun W. Characterization of chemical constituents and absorbed components, screening the active components of gelanxinning capsule and an evaluation of therapeutic effects by ultra‐high performance liquid chromatography with quadrupole time of flight mass spectrometry. J Sep Sci 2019; 42:3439-3450. [DOI: 10.1002/jssc.201900942] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2019] [Accepted: 09/17/2019] [Indexed: 11/08/2022]
Affiliation(s)
- Xin Gao
- Department of Pharmacognosy, School of PharmacyXi'an Jiaotong University Xi'an Shaanxi P. R. China
| | - Xiaohu Hu
- Xi'an Chiho Pharmaceutical Co., Ltd Xi'an Shaanxi P. R. China
| | - Qiong Zhang
- Xi'an Chiho Pharmaceutical Co., Ltd Xi'an Shaanxi P. R. China
| | - Xijing Wang
- Xi'an Xintong Pharmaceutical Research Co., Ltd Xi'an Shaanxi P. R. China
| | - Xiuhong Wen
- Xi'an Xintong Pharmaceutical Research Co., Ltd Xi'an Shaanxi P. R. China
| | - Yuan Wang
- Xi'an Xintong Pharmaceutical Research Co., Ltd Xi'an Shaanxi P. R. China
| | - Yanxia Zhang
- Xi'an Xintong Pharmaceutical Research Co., Ltd Xi'an Shaanxi P. R. China
| | - Wenjun Sun
- Xi'an Xintong Pharmaceutical Research Co., Ltd Xi'an Shaanxi P. R. China
| |
Collapse
|